These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 6106358
41. Antiparasitic agents. Part 7--Antimalarial activity of alkyl 5(6)-(4-aminophenyl) sulphonobenzimidazole-2-carbamates. Chandra S, Das PK, Dutta GP, Dutta GD, Abuzar S, Sharma S. Indian J Malariol; 1987 Jun; 24(1):17-9. PubMed ID: 3326751 [No Abstract] [Full Text] [Related]
42. [Antimalarial activity of various isoquinoline alkaloids in the mouse]. Dreyfuss G, Allais DP, Guinaudeau H, Bruneton J. Ann Pharm Fr; 1987 Jun; 45(5):361-6. PubMed ID: 3331070 [No Abstract] [Full Text] [Related]
43. In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models. Snyder C, Chollet J, Santo-Tomas J, Scheurer C, Wittlin S. Exp Parasitol; 2007 Mar; 115(3):296-300. PubMed ID: 17087929 [Abstract] [Full Text] [Related]
48. [Suppression of chloroquine resistance in Plasmodium berghei by using a microsomal monooxygenase inhibitor]. Rabinovich SA, Kulikovskaia IM, Maksakovskaia EV, Chekhonadskikh TV, Pankova TG. Med Parazitol (Mosk); 1986 Dec 19; (4):7-10. PubMed ID: 3093829 [No Abstract] [Full Text] [Related]
51. Plasmodium berghei NK65: studies on the effect of treatment duration and inoculum size on recrudescence. Nakazawa S. Exp Parasitol; 2005 Sep 19; 111(1):59-63. PubMed ID: 15961077 [Abstract] [Full Text] [Related]
52. [Chemical and biological evaluation of the effect of plant extracts against Plasmodium berghei]. Castro O, Barrios M, Chinchilla M, Guerrero O. Rev Biol Trop; 1996 Aug 19; 44(2A):361-7. PubMed ID: 9246360 [Abstract] [Full Text] [Related]
54. Effect of pyrimethamine resistance on sporogony in a Plasmodium berghei/Anopheles stephensi model. Shinondo CJ, Lanners HN, Lowrie RC, Wiser MF. Exp Parasitol; 1994 Mar 19; 78(2):194-202. PubMed ID: 8119374 [Abstract] [Full Text] [Related]
55. [Modern concepts of the pathogenesis of tropical malaria and trends in the development of a rational therapeutic procedure]. Ozeretskovskaia NN. Med Parazitol (Mosk); 1988 Mar 19; (5):3-9. PubMed ID: 3075260 [No Abstract] [Full Text] [Related]
57. The chemotherapy of rodent malaria. XVI. Primary resistance to mepacrine in the N67 strain of Plasmodium berghei-type parasite. Peters W, Gregory KG. Ann Trop Med Parasitol; 1973 Jun 19; 67(2):133-41. PubMed ID: 4578934 [No Abstract] [Full Text] [Related]
58. [New antimalarial sustained-release formulations based on bioresorbable polymers: therapeutic evaluation using the Plasmodium berghei model]. Tsakala M, Gillet J, Gillard J. J Pharm Belg; 1990 Jun 19; 45(1):5-11. PubMed ID: 2185357 [Abstract] [Full Text] [Related]
59. Preliminary observations on development of quinine sulphate resistance in Plasmodium berghei. Kazim M, Saxena R, Dutta GP. Indian J Malariol; 1986 Dec 19; 23(2):133-7. PubMed ID: 3552759 [No Abstract] [Full Text] [Related]
60. Antimalarials. Some 9-substituted amino-6-chloro-2-methoxyacridines. Stein RG, Biel JH. J Med Chem; 1973 Jan 19; 16(1):89-90. PubMed ID: 4565562 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]